» Articles » PMID: 34685747

Electrical Ventricular Remodeling in Dilated Cardiomyopathy

Overview
Journal Cells
Publisher MDPI
Date 2021 Oct 23
PMID 34685747
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ventricular arrhythmias contribute significantly to morbidity and mortality in patients with heart failure (HF). Pathomechanisms underlying arrhythmogenicity in patients with structural heart disease and impaired cardiac function include myocardial fibrosis and the remodeling of ion channels, affecting electrophysiologic properties of ventricular cardiomyocytes. The dysregulation of ion channel expression has been associated with cardiomyopathy and with the development of arrhythmias. However, the underlying molecular signaling pathways are increasingly recognized. This review summarizes clinical and cellular electrophysiologic characteristics observed in dilated cardiomyopathy (DCM) with ionic and structural alterations at the ventricular level. Furthermore, potential translational strategies and therapeutic options are highlighted.

Citing Articles

Tumour necrosis factor alpha-induced protein 3-interacting protein 3 overexpression protects against arrhythmogenic remodelling in the heart failure mice.

Yang H, Shen X, Wang H, Shuai W Europace. 2025; 27(1).

PMID: 39800969 PMC: 11757166. DOI: 10.1093/europace/euaf002.


Cardiac arrhythmias during and after thoracic irradiation for malignancies.

Heckmann M, Munster J, Finke D, Hund H, Schunn F, Debus J Cardiooncology. 2024; 10(1):81.

PMID: 39543778 PMC: 11562486. DOI: 10.1186/s40959-024-00277-3.


MicroRNA‑378: An important player in cardiovascular diseases (Review).

Wang H, Shi J, Wang J, Hu Y Mol Med Rep. 2023; 28(3).

PMID: 37503766 PMC: 10436248. DOI: 10.3892/mmr.2023.13059.


A Rare Case of Coexisting Mutation in Desmin and Thioredoxin Reductase 2 Genes Causing Dilated Cardiomyopathy.

Khatun N, Zaveri S, Salciccioli L, John S Cureus. 2023; 15(6):e40560.

PMID: 37465804 PMC: 10351334. DOI: 10.7759/cureus.40560.


Genome-wide association study of dilated cardiomyopathy-induced heart failure associated with renal insufficiency in a Chinese population.

Hu Y, Jin L, Wang Z BMC Cardiovasc Disord. 2023; 23(1):335.

PMID: 37391705 PMC: 10314512. DOI: 10.1186/s12872-023-03370-0.


References
1.
Perrin M, Gollob M . The role of atrial natriuretic peptide in modulating cardiac electrophysiology. Heart Rhythm. 2011; 9(4):610-5. DOI: 10.1016/j.hrthm.2011.11.019. View

2.
De Diego C, Gonzalez-Torres L, Nunez J, Centurion Inda R, Martin-Langerwerf D, Sangio A . Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices. Heart Rhythm. 2017; 15(3):395-402. DOI: 10.1016/j.hrthm.2017.11.012. View

3.
Curtain J, Docherty K, Jhund P, Petrie M, Inzucchi S, Kober L . Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF. Eur Heart J. 2021; 42(36):3727-3738. PMC: 8455345. DOI: 10.1093/eurheartj/ehab560. View

4.
Haas J, Frese K, Park Y, Keller A, Vogel B, Lindroth A . Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med. 2013; 5(3):413-29. PMC: 3598081. DOI: 10.1002/emmm.201201553. View

5.
Gi W, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Tappu R, Lehmann D . Epigenetic Regulation of Alternative mRNA Splicing in Dilated Cardiomyopathy. J Clin Med. 2020; 9(5). PMC: 7291244. DOI: 10.3390/jcm9051499. View